What you have now is an indolent lesion of epithelial origin, doesn't that sound better ?
The death panels aren’t going to come through the front door. They’re going to sneak up on you from behind with piano wire.
On July 29, 2013, a working group for the National Cancer Institute (the main government agency for cancer research) published a paper proposing that the term “cancer” be reserved for lesions with a reasonable likelihood of killing the patient if left untreated. Slower growing tumors would be called a different name such as “indolent lesions of epithelial origin” (IDLE).
Their justification was that modern medical technology now allows doctors to detect small, slow-growing tumors that likely wouldn’t be fatal. Yet once patients are told they have a cancer, many become frightened and seek unnecessary further tests, chemotherapy, radiation, and/or surgery.
By redefining the term “cancer,” the National Cancer Institute hopes to reduce patient anxiety and reduce the risks and expenses associated with supposedly unnecessary medical procedures. In technical terms, the government hopes to reduce “overdiagnosis” and “overtreatment” of cancer.
The death panels aren’t going to come through the front door. They’re going to sneak up on you from behind with piano wire.
On July 29, 2013, a working group for the National Cancer Institute (the main government agency for cancer research) published a paper proposing that the term “cancer” be reserved for lesions with a reasonable likelihood of killing the patient if left untreated. Slower growing tumors would be called a different name such as “indolent lesions of epithelial origin” (IDLE).
Their justification was that modern medical technology now allows doctors to detect small, slow-growing tumors that likely wouldn’t be fatal. Yet once patients are told they have a cancer, many become frightened and seek unnecessary further tests, chemotherapy, radiation, and/or surgery.
By redefining the term “cancer,” the National Cancer Institute hopes to reduce patient anxiety and reduce the risks and expenses associated with supposedly unnecessary medical procedures. In technical terms, the government hopes to reduce “overdiagnosis” and “overtreatment” of cancer.